Have a feature idea you'd love to see implemented?
Let us know!
ENZ Enzo Biochem Inc
Price (delayed)
$0.97
Market cap
$50.68M
P/E Ratio
N/A
Dividend/share
$0.1
EPS
-$0.51
Enterprise value
-$3.26M
Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous
Highlights
Enzo Biochem's debt has shrunk by 53% QoQ and by 50% YoY
The gross profit has grown by 27% YoY
Enzo Biochem's quick ratio has increased by 13% YoY but it has decreased by 12% from the previous quarter
The company's revenue fell by 4.3% QoQ but it rose by 2.7% YoY
Enzo Biochem's net income has plunged by 158% from the previous quarter
The EPS has plunged by 155% from the previous quarter
Key stats
What are the main financial stats of ENZ
Market
Valuations
Earnings
Shares outstanding
52.24M
Market cap
$50.68M
Enterprise value
-$3.26M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.89
Price to sales (P/S)
1.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.1
Revenue
$31.91M
EBIT
-$25.88M
EBITDA
-$24.61M
Free cash flow
-$26.8M
Per share
Balance sheet
Liquidity
EPS
-$0.51
Free cash flow per share
-$0.53
Book value per share
$1.09
Revenue per share
$0.63
TBVPS
$1.68
Total assets
$85.76M
Total liabilities
$29.65M
Debt
$3.43M
Equity
$56.11M
Working capital
$45.24M
Debt to equity
0.06
Current ratio
2.82
Quick ratio
2.47
Net debt/EBITDA
2.19
Margins
Efficiency
Dividend
EBITDA margin
-77.1%
Gross margin
45.9%
Net margin
-81.7%
Operating margin
-38.8%
Return on assets
-27.1%
Return on equity
-38.6%
Return on invested capital
-159.7%
Return on capital employed
-42.4%
Return on sales
-81.1%
Dividend yield
10.31%
DPS
$0.1
Payout ratio
N/A
ENZ stock price
How has the Enzo Biochem stock price performed over time
Intraday
-1.73%
1 week
-14.91%
1 month
-14.91%
1 year
-23.02%
YTD
-30.22%
QTD
-13.39%
Financial performance
How have Enzo Biochem's revenue and profit performed over time
Revenue
$31.91M
Gross profit
$14.63M
Operating income
-$12.37M
Net income
-$26.08M
Gross margin
45.9%
Net margin
-81.7%
Enzo Biochem's net margin has shrunk by 161% QoQ
Enzo Biochem's net income has plunged by 158% from the previous quarter
The operating margin has soared by 51% YoY and by 23% from the previous quarter
The operating income has soared by 50% YoY and by 27% from the previous quarter
Growth
What is Enzo Biochem's growth rate over time
Valuation
What is Enzo Biochem stock price valuation
P/E
N/A
P/B
0.89
P/S
1.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.1
The EPS has plunged by 155% from the previous quarter
The P/B is 55% less than the 5-year quarterly average of 2.0
ENZ's equity is down by 28% YoY and by 19% from the previous quarter
The P/S is 25% below the 5-year quarterly average of 2.1 and 17% below the last 4 quarters average of 1.9
The company's revenue fell by 4.3% QoQ but it rose by 2.7% YoY
Efficiency
How efficient is Enzo Biochem business performance
ENZ's ROE has shrunk by 183% YoY and by 163% QoQ
ENZ's ROA has dropped by 164% since the previous quarter
The ROS has plunged by 162% from the previous quarter
The ROIC has plunged by 159% from the previous quarter
Dividends
What is ENZ's dividend history
DPS
$0.1
Dividend yield
10.31%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Enzo Biochem financials performed over time
ENZ's total assets is 189% greater than its total liabilities
The total liabilities has contracted by 32% YoY but it has grown by 21% from the previous quarter
ENZ's total assets is down by 30% year-on-year and by 8% since the previous quarter
Enzo Biochem's debt is 94% lower than its equity
Enzo Biochem's debt has shrunk by 53% QoQ and by 50% YoY
The debt to equity has contracted by 45% from the previous quarter and by 33% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.